top left cornertop right corner
Blackburn with Darwen Primary Care Trust - About Us
.

Medicines Management in the East Lancashire Health Economy

Information on this website has been provided by the East Lancashire Medicines Management Board which oversees Medicines Management issues across the East Lancashire Health Economy (population 522,000), which consists of;

 

 

The Medicines Management Board (MMB)  consists of physicians and representatives of other key decision-makers in the use of medicines in primary and secondary care. The remit of this board is to review selected pharmaceutical products to assess their clinical value, safety and suitability for use in the East Lancashire Health Economy, and to guide all prescribers in primary and secondary care in using them appropriately.

 

Typical drugs that are considered include newly licensed drugs or those that have a new indication and drugs used to treat conditions with which primary care prescribers may be less familiar. Unlicensed drugs and individual requests are also considered. Requests for drugs to be reviewed may be made by any health care professional in the East Lancashire Health Economy.

The recommendations of the MMB and the evidence considered in the evaluations are summarised in the New Drug Reviews. When use with a shared care agreement is recommended for a particular drug an effective Shared Care Agreement is provided for local use. These documents are available on the website under " New Drug Reviews ” and “ Shared Care Protocols ” respectively.  

 

Any decisions on drug use are also included into the Joint Medicines Formulary, which acts as a

reference to medicines approved for use in East Lancashire.  The Joint Medicines Formulary is formatted in the same style of the BNF, and provides all prescribers with a defined list of medicines that are available to prescribe, as well as the traffic light recommendation for each and any other recommendations for their use.  The Joint Medicines Formulary is available on the website under the “ Medicines Formulary ” heading above. Within East Lancashire a Joint Wound Care Formulary has also been developed, which forms the basis for the prescribing of cost effective and evaluated wound care products, as well as giving guidance on selection of dressing, specialist products, and available sizes.  It is available on the website under the " Wound Care Formulary " heading above.

 

The MMB also provides supporting information on some general prescribing issues (e.g. product withdrawals) as well as ratifying prescribing and clinical guidelines, treatment protocols and integrated care pathways for use across East Lancashire, all of which can be found above under  "Guidelines ".

 

Latest decisions of the MMB are listed on the MMB website update email that is sent out each month.  Health care professionals in East Lancashire can also register to receive this and other news by clicking on the link at the top of the page.  Planned activities and other relevant news items can be found in our monthly newsletter  INTERFACE that is distributed to all healthcare professionals across East Lancashire and is also available online under the heading “ Newsletters & Minutes ” on the left hand navigation panel.

 

For Freedom of Information Requests, please contact:

foi@bwd.nhs.uk – NHS Blackburn with Darwen

foi@eastlancspct.nhs.uk – NHS East Lancashire

 

This website only uses essential, non-intrusive cookies, which are removed from your computer once you've left.

Click here to learn more about cookies.

 

 

Latest Updates by Section

INTERFACE - Latest Edition

NICE Bites - Latest Edition

 

MHRA Drug Safety Update -

Latest Edition

 

Shared Care Guidelines

 

23rd July 2014

 

Memantine Shared Care Guideline


Shared Care Guidelines

 

23rd July 2014

 

Donepezil, Galantamine, Rivastigmine Shared Care Guideline


Newsletters and Minutes

 

22nd July 2014

 

Latest MHRA Drug Safety Update


 

MHRA - E-learning modules

 

22nd July 2014

 

E-learning modules on adverse drug reactions


 

Drug Alerts and Withdrawals

 

22nd July 2014

 

Class 2 medicines recall: amoxycillin sodium 500mg powder for solution for injection


 

Drug Alerts and Withdrawals

 

21st July 2014

 

Class 2 medicines recall: Midazolam Buccal Liquid 10mg/1ml, 5ml (Penn Pharma)


 

 

Drug Alerts and Withdrawals

 

18th June 2014

 

Class 2 Medicines Recall: Clarithromycin 500mg powder for solution for Infusion in Agila livery


Drug Alerts and Withdrawals

 

17th June 2014

 

Company-led drug recall: Soliris (eculizumab) 300mg conc for solution for Infusion


 

Condition Specific Guidelines

 

17th June 2014

 

ELHE Adult Asthma Guidelines


Condition Specific Guidelines

 

17th June 2014

 

Primary Care Management of COPD


Newsletters and Minutes

 

12th June 2014

 

NICE BItes - latest edition June


 

Drug Alerts & Withdrawals

 

12th June 2014

 

Class2 Medicines Recall - Vancomycin Powder for Concentrate for Infusion


 

Drug Alerts & Withdrawals

 

10th June 2014

 

Accu-Check blood glucose meter (ROCHE) Medical Device Alert


 

Newsletters and Minutes

 

6th June 2014

 

Medicines Management Board Minutes


 

 

Disease and Condition  Specific Guidelines 

 

22nd May 2014

 

Guideline on Diagnosis & Management of Vitamin D Deficiency in Adults for Non-Specialists (revised)


 

Formulary updates

 

7th May 2014

 

Shared Care Guideline -Denosumab 60mg injection


Newsletters and Minutes

 

7th May 2014

 

NICE Bites April 2014


 

Patient Group Directions

 

6th May 2014

 

Varicella PGD

 

dTaP/IPV & DTap/IPV PGD

 


Patient Group Directions 

 

6th May 2014

 

PGD Group Terms of Reference

 

Memorandum of Understanding Between NHS England (Lancashire Area Team) & Cumbria and Lancashire Vaccination and Immunisation PGD Group for development & authorisation of vaccination & immunisation PGDs


Formularymulary

 

28th April 2014

 

Joint Wound Care Formulary 

 

Dressing Prescription Request Form (updated)

 


 

Formulary

 

28th April 2014

 

Management of Moisture Lesions and Incontinence Associated Dermatitis


 

Formulary Updates

 

23rd April 2014

 

Joint Catheter and Continence Formulary


Formulary Updates

 

23rd April 2014

 

Relvar Ellipta - GREY Under Review


NICE Formulary Updates

 

23rd April 2014

 

Aflibercept - Black Traffic Light as per NICE TAG 307

 

Rituximab in combination with glucocorticoids for treating anti-neutrphil cytoplasmic antibody-associated vasculitis recommended as an option by NICE TAG 308

Red Traffic Light


 

Newsletters and Minutes

 

3rd April 2014

 

NICE Bites - March 2014 edition updated


 

Drug Alerts and Withdrawals

 

3rd April 2014

 

MHRA and NHS England in initiative to simplify adverse incident reporting


Formulary Update

 

1st April 2014

 

Fosfomycin  - Guidance and Prescribing proforma for GPs


 

Drug Alerts and withdrawals

 

11th March 2014

 

Class 2 Medicines Recall - Viread 245mg film coated tablets


 

Care Homes

 

6th March 2014

 

Care Homes - Hospital Admission Checklist for transfer of medicines between care home and hospital


Drug Alerts and Withdrawals

 

3rd March 2014

 

Company led recall:Doribax (doripenem) 500mg powder for solution


 

Newsletters and Minutes

 

28th February 2014

 

NICE Bites - latest edition


 Drug Alerts and Withdrawals

 

19th February 2014

 

Class 2 Medicines Recall - Cosopt

Preservative-Free, 20mg/ml +5mg/ml,

eye drops, solution, single-dose container


Newsletters and Minutes

 

17th February 2014

 

Drug Safety Update February 2014


Newsletters and Minutes

 

29th January 2014

 

NICE Bites 


Newsletters and Minutes

 

22nd January 2014

 

Drug Safety Update January 2014

 

 


Patient Group Directions

 

January 2014

 

Hepatis A + B 2014

 

Hepatitis B  2014

 

Pneumococcal Conjugate 2014

 

Seasonal Influenza 2014


 

ELHT Prescribing Accuracy Audit

 

January 2014

 

Prescribing Accuracy Audit Report


Other Clinical Guidelines

 

January 2014

 

Antibiotics Patient Information Leaflet ELHT


Disease or Condition Specific Guidleines 

 

January 2014

 

Biologics Flexes on the use of Anti-TNFα and other Biologics in the Rheumatoid Arthritis Clinical Pathway


Minutes and Newsletters

 

January 2014

 

ELMMB Minutes  December 2013


 

Medicine Specific Guidelines

 

January 2014nuary 2014

 

Xiapex (Collagenase clostridium histolyticum) Policy


Palliative Care

 

January 2014

 

Guidelines for the managament of symptoms in the last days of life - Pennine Lancs


Other Clinical Guidelines

 

January 2014

 

Guidelines for Good Prescribing in Primary care 


Disease or Condition Specific Guidleines

 

January 2014

 

Lancashire HIV Formulary - revised


Other Clinical Guidelines

 

January 2014

 

Prescribing Infant Formulas - Quick reference Guide


 

Medicine Specific Guidelines

 

January 2014

 

Prescribing Guidelines for NOACs in AF


Non Clinical Guidelines

 

January 2014

 

Outpatient Prescriptions Patient Information Leaflet ELHT


Palliative Care

 

January 2014

 

Topical Morphine Guidelines ELHE


Other Clinical Guidelines

 

January 2014

 

Protocol for Ordering, Switching and supply of COPD inhalers ELHT


Condition Specific Guidelines

January 2014 

Exenatide/Liraglutide New Patient Treatment/ Agreement Form

 

Exenatide/Liraglutide Review Treatment Agreement

 

Richard Lee, East Lancashire Health Economy New Drugs Pharmacist.

Email: Interface@bwd.nhs.uk

Powered by EasySite™ Content Management System